Hemangiosarcoma

Also known as: Angiosarcoma / Angiosarcomas / Angiosarcoma (morphologic abnormality) / Hemangiosarcoma (morphologic abnormality) / Haemangiosarcoma NOS / Haemangiosarcoma / Angiosarcoma NOS / Angiosarcoma (disorder) / Haemangioendothelioma malignant / Hemangioendothelioma, malignant (morphologic abnormality) / Hemangioendothelioma malignant

DrugDrug NameDrug Description
DB00398SorafenibA kinase inhibitor used in the treatment of unresectable liver carcinoma and advanced renal carcinoma.
DrugDrug NameTargetType
DB00398SorafenibSerine/threonine-protein kinase B-raftarget
DB00398SorafenibReceptor-type tyrosine-protein kinase FLT3target
DB00398SorafenibRAF proto-oncogene serine/threonine-protein kinasetarget
DB00398SorafenibVascular endothelial growth factor receptor 3target
DB00398SorafenibPlatelet-derived growth factor receptor betatarget
DB00398SorafenibMast/stem cell growth factor receptor Kittarget
DB00398SorafenibVascular endothelial growth factor receptor 2target
DB00398SorafenibCytochrome P450 3A4enzyme
DB00398SorafenibUDP-glucuronosyltransferase 1-9enzyme
DB00398SorafenibCytochrome P450 2B6enzyme
DB00398SorafenibCytochrome P450 2C8enzyme
DB00398SorafenibCytochrome P450 3A5enzyme
DB00398SorafenibCytochrome P450 3A7enzyme
DB00398SorafenibCytochrome P450 2C9enzyme
DB00398SorafenibMultidrug resistance-associated protein 4transporter
DB00398SorafenibP-glycoprotein 1transporter
DB00398SorafenibCanalicular multispecific organic anion transporter 1transporter
DB00398SorafenibATP-binding cassette sub-family G member 2transporter
DB00398SorafenibCytochrome P450 1A2enzyme
DB00398SorafenibCytochrome P450 2C19enzyme
DB00398SorafenibCytochrome P450 2D6enzyme
DB00398SorafenibUDP-glucuronosyltransferase 1-1enzyme
DB00398SorafenibRalA-binding protein 1transporter
DB00398SorafenibFibroblast growth factor receptor 1target
DB00398SorafenibProto-oncogene tyrosine-protein kinase receptor Rettarget
DB00398SorafenibVascular endothelial growth factor receptor 1target
DB00398SorafenibSolute carrier organic anion transporter family member 1B1transporter
DrugDrug NamePhaseStatusCount
DB15676Balstilimab1Recruiting1
DB16651Botensilimab1Recruiting1
DB00571Propranolol1 / 2Unknown Status1
DB160479-ING-412Withdrawn2
DB12001Abemaciclib2Recruiting1
DB15676Balstilimab2Withdrawn1
DB00112Bevacizumab2Completed2
DB00112Bevacizumab2Terminated1
DB14707Cemiplimab2Recruiting1
DB00380Dexrazoxane2Active Not Recruiting1
DB01248Docetaxel2Completed1
DB01248Docetaxel2Withdrawn2
DB15627Dostarlimab2Recruiting1
DB00997Doxorubicin2Active Not Recruiting1
DB00997Doxorubicin2Recruiting1
DB11714Durvalumab2Recruiting1
DB08871Eribulin2Recruiting1
DB12047Ganetespib2Recruiting1
DB12205Ganitumab2Recruiting1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Withdrawn2
DB06186Ipilimumab2Recruiting1
DB00762Irinotecan2Recruiting1
DB15409Ladiratuzumab vedotin2Recruiting1
DB01006Letrozole2Recruiting1
DB14123Menthol2Recruiting1
DB00331Metformin2Recruiting1
DB11828Neratinib2Recruiting1
DB09035Nivolumab2Recruiting1
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Completed1
DB01229Paclitaxel2Recruiting1
DB01229Paclitaxel2Terminated2
DB12090Patritumab2Recruiting1
DB06589Pazopanib2Terminated1
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Recruiting1
DB12978Pexidartinib2Recruiting1
DB00571Propranolol2Recruiting1
DB11760Talazoparib2Recruiting1
DB00072Trastuzumab2Recruiting1
DB16342Trastuzumab duocarmazine2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB12056Trebananib2Recruiting1
DB15442Trilaciclib2Recruiting1
DB11652Tucatinib2Recruiting1
DB07232Veliparib2Recruiting1
DB15632Zalifrelimab2Withdrawn1
DB00965Ethiodized oil4Recruiting1
DB08896RegorafenibNot AvailableRecruiting1